Page 48 - Annual report 2021-22
P. 48

Annual Report 2021-22 |


               and a complicated graft preparation process. Moreover, no “Made in India” bioengineered skin graft
               is available for clinical use and importing these materials is costly and impractical due to their short
               shelf-life. Implantation of isolated epidermal and dermal cells is a viable alternative. However, the
               implanted  primary  cells  need  structural  and  microenvironmental  support  for  proper  growth  and
               function. This structural and microenvironment support is provided by the extracellular matrix (ECM)
               in normal skin. In severe wounds, there is a significant loss of ECM, hence transplantation of cultured    31
               skin  cells  does  not  yield  expected  outcomes  due  to  the  poor  mechanical  and  structural  support.
               Development of an easy indigenous technique for making a clinically viable bioengineered autologous
               skin cell graft would be beneficial for millions of patients. Keeping these in mind, an autologous cell
               embedded bio-scaffold is being developed as a complete skin substitute.
               MicroRNAs in vitiligo skin

               Identification of the repair response pathways in melanocytes that are activated during pigmentation
               with an implication towards their loss in vitiligo. miRNAs were successfully extracted and enriched
               from pigmented vs depigmented skin (day 14 post-wound) of 5 vitiligo patients. Data was normalized
               and differentially expressed miRNAs were identified in depigmented skin (compared to pigmented
               skin). Real-time PCR was used to validate some of the most upregulated and downregulated miRNAs
               in vitiligo skin during wound healing. Commercially available stem cell lines (H9ESCs stem cell HSCs /
               IMR90  hiPSC)  have  been  used  for  differentiation  and  generation  of  organoids  instead  of
               reprogramming.

               Bioscaffolds for skin therapeutics

               Archana’s  group  has  developed  a  simple  way  of  making  cell  embedded  scaffolds  using  the
               polyelectrolyte complexation (PEC) technique, utilizing chitosan (CH) as a positively charged polymer
               and a mixture of chondroitin sulphate (CS) and hyaluronic acid (HA) as negatively charged polymers.
               When these polymer solutions are mixed, there is spontaneous electrostatic interaction leading to the
               formation  of  a  cross-linked  scaffold.  As  this  technique  produces  no  by-products  and  only  uses  a
               polymer solution for making the scaffold, primary skin cells can be added easily during the scaffold
               formation process. Two different compositions of the PEC, one with CH and CS (CH-CS PEC), another
               with CH and CS+HA [CH-(CS-HA) PEC] were explored, for their ability for the complete grafting of
               keratinocyte and fibroblast cells. Following physicochemical characterization, hemocompatibility and
               protein adsorption studies, the scaffold's ability to engraft keratinocytes was evaluated by microscopic
               examination. Finally, expression of proliferation and functional markers by the keratinocyte cells were
               compared  between  seeded  and  grafted  cells  on  the  same  scaffold,  to  understand  the  impact  of
               complete cellular grafting on the cellular behaviour.  In future, this study will lead to the differences
               between  grafted  and  seeded  cells  using  cellular  and  molecular  assays.  This  includes  analysis  of
               proliferation  and  differentiation  markers  of  keratinocytes,  melanocytes  and  fibroblasts  using
               quantitative PCR based methods.
   43   44   45   46   47   48   49   50   51   52   53